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Highlights 
 There was an association between telomere length and physical performance 
 Greater telomere attrition was associated with poorer physical performance 
 Results were significant only for women 
 Telomeres could potentially be used as a biomarker of physical performance 
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Abstract 
Telomere length has been suggested a biomarker of aging and is associated with several chronic 
diseases. However, the association between telomere length and physical performance is not well 
known. Using both cross-sectional and longitudinal data, we studied 582 women and 453 men from 
the Helsinki Birth Cohort Study at two time-points; a baseline examination in 2001-2004 at a mean 
age of 61 years and a follow-up examination approximately 10 years later in 2011-2013. Telomere 
length was measured both at baseline and at follow-up using real-time quantitative polymerase chain 
reaction. Physical performance was evaluated only at follow-up using the Senior Fitness Test (SFT), 
which assesses strength, flexibility and endurance. In women, shorter telomere length at follow-up 
(p=0.044) and greater telomere attrition during follow-up time (p=0.022) were associated with poorer 
physical performance after adjusting for covariates (age at baseline, smoking status, body mass index 
at baseline, follow-up time and educational attainment). No similar associations were found for men. 
This indicates that, at least in women, telomere length could potentially be used as a biomarker for 
physical performance, however, more longitudinal studies are needed to confirm this association. 
 
Keywords: Biomarkers, Physical function, Aging, Epidemiology 
 
Abbreviations 
HBCS, Helsinki Birth Cohort Study; LTPA, leisure-time physical activity; MET, metabolic 
equivalent of task; SFT, Senior Fitness Test 
 
1. Introduction 
Aging can be defined as a gradual event causing decline in biological functions and is a major risk 
factor for both morbidity and mortality (Simm et al., 2008). However, due to the heterogeneity of the 
aging process, chronological age is a poor indicator of health and function (Mitnitski et al., 2002). 
Therefore, studies from the past decade have used other methods for assessing the biological age of 
an individual (Martin-Ruiz et al., 2011). Telomere length has been proposed as one potential 
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biomarker of aging (von Zglinicki and Martin-Ruiz, 2005). Telomeres are repetitive nucleoprotein 
complexes at the ends of eukaryotic chromosomes that protect functional DNA (Blackburn, 2001). 
Telomeres shorten at each cell division due to incomplete DNA replication at chromosome ends, 
however, the rate of telomere attrition is further induced by inflammation and oxidative stress as well 
as e.g. smoking and obesity (Lorenzi et al., 2018). Telomere length has been shown to correlate 
inversely with age and several age-related diseases including type 2 diabetes, cardiovascular disease, 
renal failure and Alzheimer’s disease (Bernadotte et al., 2016). The association between telomere 
length and mortality has been inconsistent in previous studies (Cawthon et al., 2003; Martin‐Ruiz et 
al., 2005).  
 
Among older people, physical performance is an important indicator of both current and future health 
status. With decreased physical function, the risk of morbidity such as cardiovascular disease and 
cognitive decline increases, and poor physical performance also predicts future hospitalization and 
institutionalization (Cooper et al., 2010a). In community-dwelling populations, objectively measured 
poor physical performance has been shown to increase the risk of all-cause mortality (Cooper et al., 
2010b). Aging is associated with a loss of muscle mass, known as sarcopenia, which is an important 
reason for decreased physical function among older people (Legrand et al., 2014). To avoid rises in 
health care costs (Fried et al., 2001) there is an inevitable need for finding ways to predict and prevent 
decline in physical performance at an early stage among older people.  
 
The association between telomere length and physical performance is not well known. Only little 
evidence is available and the results have been inconsistent, most having shown no association 
between the two variables (Mather et al., 2010; Maynard et al., 2015). Cross-sectional studies have 
assessed telomere length at only one time-point thereby unable to report any change in telomere 
length over time. As inflammation and oxidative stress are associated with both decreased physical 
performance and increased rate of telomere attrition, an attractive hypothesis is that changes in 
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telomere length better predicts subsequent physical decline compared to using a single measure of 
telomere length. Previous longitudinal studies have assessed physical performance using simple test 
batteries only assessing limited aspects of physical performance, such as grip strength or standing 
balance (Gardner et al., 2013). These tests may thereby not give an accurate representation of the 
overall physical performance of the individuals. 
 
The aim of this study was to assess if telomere length was related to objectively measured physical 
performance 10 years later. We also assessed if telomere attrition over a 10-year period or telomere 
length in cross-sectional analysis was associated with physical performance. We studied individuals 
from the Helsinki Birth Cohort Study at an average age of 61 years and assessed physical performance 
with the validated Senior Fitness Test (SFT). 
 
 
2. Material and methods 
2.1. Study population 
This study is part of the Helsinki Birth Cohort Study (HBCS) and uses data from a subpopulation of 
the HBCS consisting of 8760 individuals born between 1934 and 1944 at the Helsinki University 
Central Hospital. All subjects visited child welfare clinics in Helsinki and were residents of Finland 
in 1971, when they received a unique personal identification number (Åström et al., 2018). In the 
year 2000, random-number tables were used to invite 2902 individuals to a baseline clinical 
examination, of which 2003 cohort members participated in an examination between 2001 and 2004. 
From this clinical cohort, those still alive and living within a 100-km radius of Helsinki were invited 
to a follow-up examination in 2011. A total of 1097 of the invited 1404 cohort members participated 
in this follow-up examination between 2011 and 2013. The present study sample consists of 1035 
cohort members with adequate data on both telomere length and physical performance. The clinical 
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study protocol was approved by the Coordinating Ethics Committee of the Hospital District of 
Helsinki and Uusimaa and follows the guidelines of the Declaration of Helsinki. A written, informed 
consent was obtained from all participants.  
 
2.2. DNA extraction and telomere length 
DNA was extracted from EDTA-anti-coagulated peripheral whole blood both at the baseline clinical 
examination in 2001-2004 and at the clinical follow-up examination in 2011-2013 using a 
commercially available kit, QIAamp Blood Maxi Kit and DNeasy Blood & Tissue Kit (Qiagen, The 
Netherlands), respectively. The samples were stored at -20°C before and after DNA extraction. DNA 
concentration and purity were assessed by measuring ultraviolet absorbance at 260nm for salts and 
280nm for other contaminants. DNA integrity was tested by electrophoresis in 0.8% agarose gel. 
There was no difference in DNA integrity and quality between the two kits. 
 
Telomere length was assessed in leukocytes and measured using real-time quantitative polymerase 
chain reaction (PCR) as previously described (Guzzardi et al., 2015). At the baseline examination, 
telomere length was determined as the ratio of telomere DNA intensity to hemoglobin beta single-
copy gene signal intensity (Cawthon, 2002; Kajantie et al., 2012; O'Callaghan et al., 2008). A 
multiplex real-time quantitative PCR using a 384-well plate (CFX384 Touch Real-Time PCR 
Detection System, Bio-Rad Laboratories, USA) was used to measure telomere length at the follow-
up examination (Cawthon, 2009; Guzzardi et al., 2015). All plates included 3 or 4 genomic DNA 
control samples for calibrating the plate effect and for monitoring the inter-assay coefficient of 
variation, which was 21.0% at baseline and 6.2% at the follow-up examination. Telomere length at 
both time points correlated with each other (r=0.255, p<0.001). 
 
Telomere length is expressed as a T/S ratio, calculated as the ratio of telomere repeat copy number 
(T) to single gene copy number (S) for each sample compared to a reference sample. Absolute change 
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in telomere length during follow-up was calculated by subtracting baseline telomere length from 
follow-up telomere length. Relative telomere length after the follow-up period was calculated as 
follow-up telomere length divided by telomere length at baseline.  
 
2.3. Physical performance 
Physical performance was assessed at the follow-up examination in 2011-2013 using the validated 
SFT (Rikli and Jones, 1999). A modified test battery consisting of 5 tests was used to objectively 
evaluate the level of physical fitness: 1) Arm curl: holding hand weight (2kg for women and 3kg for 
men), number of full-range biceps curls during 30-s to assess upper-body strength; 2) Chair stand: 
number of full chair stands during 30-s with arms folded across chest to evaluate lower-body strength; 
3) Chair sit-and-reach: sitting at the front of the chair with legs fully extended, distance (in 
centimeters) between extended fingers and tip of toes to assess lower-body flexibility; 4) Back 
scratch: number of centimeters between tip of extended fingers, with one hand reaching over shoulder 
and the other hand up middle of back to evaluate upper-body flexibility; 5) 6-min walk: number of 
meters walked in 6 minutes to assess aerobic endurance. All tests were performed at a research facility 
and measurements were done by trained research assistants.  
 
For each test, sex-standardized percentile tables of normative data for 5-year age groups were used 
to rate the score of the participants (Rikli and Jones, 2013). Based on 5-percentile ranges, the rating 
for each test varied between 1 and 20, those with a score in the lowest 5-percentiles receiving a rating 
of 1 and those with a score in the highest 5-percentiles receiving a rating of 20. The overall SFT score 
was then calculated by summing the normalized ratings of the SFT test components and varied 
between 5 and 100. 
 
2.4. Study variables and covariates 
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At the baseline examination, height and weight were measured and body mass index (BMI) was 
calculated as kg/m2. Information on current health status, disease history, smoking status, level of 
education and lifestyle characteristics were acquired using questionnaires. Blood was drawn after 
fasting in order to measure glucose and lipids. The Kuopio Ischaemic Heart Disease Risk Factor 
Study (KIHD) 12-month leisure-time physical activity (LTPA) history questionnaire was used to 
assess physical activity (Lakka and Salonen, 1992). This validated exercise questionnaire assigns a 
metabolic equivalent of task (MET) value based on intensity grade for the most common LTPA and 
assesses physical activity during the last 12 months. The results are presented as MET-hours per year. 
 
2.5. Statistical analysis 
Data are presented as means with standard deviations (SD) or as counts with percentages. The study 
population was divided into tertiles based on the overall SFT score. In univariate analysis, linearity 
across SFT tertiles for baseline variables and telomere measurements were evaluated using the 
Cochran-Armitage test for trend and analysis of variance (ANOVA) with an appropriate contrast. In 
the adjusted model, linearity (orthogonal polynomial) of telomere measurements across SFT tertiles 
was evaluated using analysis of covariance (ANCOVA) and regression analysis. In the case of 
violation of the assumptions (e.g. non-normality), a bootstrap-type test was used. In the adjusted 
model, we controlled for age at baseline, smoking status, BMI at baseline, follow-up time and years 
of education. A possible nonlinear relationship between SFT and relative telomere length at follow-
up was assessed using 3-knot-restricted cubic spline regression. The length of the distribution of knots 
were located at the 10th, 50th, and 90th percentiles; knot locations were based on Harrell's 
recommended percentiles or user-specified points (Harrell Jr., 2001). Correlation coefficients with 
95% CI were calculated using the Spearman method. The normality of the variables was tested using 
the Shapiro–Wilk W test. Stata 15.1 (StataCorp LP; College Station, Texas, USA) statistical package 
was used for the analysis. 
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3. Results 
Characteristics for the 582 women and 453 men included in the analysis are shown in Table 1. 
Baseline measurements were assessed at a mean age of 61 (SD 3) years. Physical performance was 
measured 9.7 years later (range 7.7 to 11.5 years). For both men and women, those with the highest 
BMI, highest glucose and triglyceride levels as well as the lowest HDL cholesterol fell into the lowest 
tertile of the SFT. The prevalence of cardiovascular disease and diabetes were highest in the lowest 
SFT tertile, whereas individuals with the highest education had the best physical performance, for 
both men and women. In addition, smoking status showed a negative association and LTPA a positive 
association across SFT tertiles for women but not men.  
 
Mean telomere length T/S ratio at baseline was 1.42 (SD 0.29) for women and 1.38 (SD 0.29) for 
men, whereas the corresponding values at follow-up were 0.89 (SD 0.32) and 0.81 (SD 0.27) for 
women and men, respectively. Table 2 presents the unadjusted associations between telomere length 
measurements and SFT score tertiles. Telomere length at baseline was not associated with the SFT 
score 10 years later for neither women (p=0.87) nor men (p=0.45). At follow-up, however, longer 
telomere length was associated with a higher overall SFT score for women (p=0.021) but not for men 
(p=0.56). Adjustment for age at baseline, smoking status, BMI at baseline, follow-up time and years 
of education attenuated the association but it remained statistically significant for women (p=0.044) 
and non-significant for men (p=0.13). Greater absolute telomere change between baseline and follow-
up examinations was also associated with a lower overall SFT score, but only for women (p=0.039). 
Adjusting for age at baseline, smoking status, BMI at baseline, follow-up time and years of education 
did not attenuate this association (p=0.022). The corresponding p-values for men were p=0.86 (crude) 
and p=0.65 (adjusted). Similarly, there was a linear association between relative telomere length at 
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follow-up and the SFT score for women but not for men. No correlation was found between telomere 
measurements and individual SFT components in neither women nor men (Table 3). 
 
Figure 1 shows a scatter-plot on the association between baseline telomere length and SFT at follow-
up. Baseline telomere length was not related to physical performance at follow-up in women (β=-
0.02, 95% CI -0.10 to 0.05) or in men (β=0.00, 95% CI -0.09 to 0.09). The corresponding coefficients 
for the association between follow-up telomere length and physical performance for women (β=-0.09, 
95% CI 0.00 to 0.17) and men (β= 0.04, 95% CI -0.05 to 0.13) are shown in figure 2. The association 
between SFT score and relative telomere length after follow-up is illustrated in Figure 3. Greater 
relative telomere length was associated with better physical performance, but only in women. 
 
4. Discussion 
In this cohort study of older people, we found a linear association between telomere length and 
physical performance among women in cross-sectional analysis. No similar association was observed 
for men. In addition, greater change in telomere length during the 10-year follow-up correlated with 
poorer physical performance among women but not men. Controlling for BMI, smoking and years of 
education did not attenuate the associations.  
 
Ideally, telomere length could be used as a marker to assess and predict multicomplex age-related 
conditions, including decline in physical performance. However, findings in previous studies on the 
association between telomere length and physical performance have been inconsistent. In a meta-
analysis by Gardner and colleagues (Gardner et al., 2013) comprising 4 studies, only chair rise speed 
and grip strength showed weak associations with telomere measurements. However, telomere length 
did not correlate with the other tests of physical performance, including walking speed and balance. 
Similarly, the Cardiovascular Health Study found a positive association between telomere length and 
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chair stand result (Soares-Miranda et al., 2015). Some studies have also assessed the association 
between telomere length and frailty. Our earlier findings from the Helsinki Birth Cohort Study 
showed an inverse association between telomere length and risk of frailty (Haapanen et al., 2018). In 
contrast, a meta-analysis consisting of 3268 participants found no association between the two 
variables (Zhou et al., 2018). 
 
Telomere length can be linked to physical performance by both direct and indirect pathways. When 
telomeres reach a critical point of shortening (less than 200–300 base pairs), cell cycle arrest, cellular 
senescence and apoptosis are triggered, which may cause loss of functional tissue (Aubert and 
Lansdorp, 2008). Thus, loss of muscle mass and muscle function due to telomere attrition could be a 
cause of poor physical performance (Zaslavsky et al., 2013). Another possible mechanism is oxidative 
stress and chronic inflammation, which has been shown to correlate with both telomere attrition 
(Lorenzi et al., 2018) and poor physical performance among older people (Cesari et al., 2004). This 
explanation is further supported by previous findings showing that senescent cells also secrete 
inflammatory mediators, such as interleukin-6 (Rodier et al., 2009).  
 
Several reasons may account for the inconsistent findings in previous studies on the association 
between telomere length and physical performance. An obvious reason is differences in sample size, 
as smaller studies may not have enough statistical power to show an association. Another reason for 
discrepancy between results may be the technique used for measuring telomere length. The 
interindividual variation of telomere length is large and quantitative PCR has been shown to have a 
high coefficient of variation (Martin-Ruiz et al., 2015). If follow-up time in longitudinal studies is 
inadequate, this may lead to undetectable changes in telomere length and thereby non-significant 
results. Finally, the age-range of the study population could affect the results, as telomere length may 
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be a stronger predictor of health outcomes for younger adults compared to older people (Brown et 
al., 2018). 
 
We found that telomere attrition and telomere length associated with physical performance only 
among women, and this may be due to several factors. There were greater differences in lifestyle 
characteristics among women with better physical performance compared to men, regarding e.g. 
smoking and prevalence of cardiovascular disease, which could explain the difference observed in 
the association between the sexes. Besides evaluating muscle strength, the SFT used in our study also 
tests for flexibility, which may be another reason we found a relationship between the overall SFT 
score and physical performance only in women. Previous studies have generally reported longer 
telomere length in women (Woo et al., 2008; Yu et al., 2015), which may be due to hormonal 
differences between the sexes. Estrogen has been shown to upregulate telomerase activity, which 
increases the regeneration potential of telomeres (Kyo et al., 1999). In addition, estrogen reduces the 
burden of oxidative stress, thereby decreasing the rate of telomere attrition (Aviv, 2002). On the other 
hand, longer telomeres at baseline have been shown to correlate with a higher telomere attrition rate 
(Nordfjäll et al., 2009). Thus, although women have slower telomere attrition at younger age, the 
longer telomere length at older age may cause greater relative change in telomere length compared 
to men, when studying older people. 
 
The strengths of this study are numerous. In this longitudinal study we included over 1000 well-
phenotyped men and women who were followed-up for almost 10 years. Physical performance was 
assessed objectively using the validated SFT, which can be considered an appropriate method for 
measuring physical performance. SFT evaluates strength, flexibility and endurance, all important 
components of physical function. Furthermore, we measured telomere length at two time points, 
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which allowed us to investigate how telomere attrition over time correlates with physical 
performance. 
 
A weakness of this study is that we did not measure physical performance at baseline. We were 
therefore not able to evaluate a potential change in physical performance during follow-up and 
investigate if this correlates with either telomere length or telomere attrition. We found no association 
between baseline telomere length and physical performance 10 years later, thus, the follow-up time 
needed for predictive results remains unclear. Although the SFT measures overall physical 
performance, it should be noted that 40% of the score consists of measures on flexibility but no 
exhaustive test on endurance is included. This warrants further studies on the topic as different 
performance test batteries may reveal other kind of associations. We were able to account for several 
covariates in the analyses including BMI and smoking but acknowledge the possibility of other 
unmeasured variables affecting our results. We assessed telomere length from peripheral blood 
leukocytes, however, we cannot exclude that telomere length measured from e.g. muscle cells would 
better correlate with physical performance. Telomere length has been shown to have high heritability 
(Broer et al., 2013) and our study consisted of a homogenous group of participants living in a 
restricted area of Finland. This should be considered before generalizing our results. 
  
In conclusion, we found evidence suggesting that shorter telomere length in cross-sectional analysis 
and greater telomere attrition over a 10-year period were associated with poorer physical performance 
among older women. However, further longitudinal studies with sufficient follow-up times and larger 
study populations assessing physical performance at all time points are needed to confirm these 
findings in order to evaluate the usability of telomere length as a biomarker for physical performance. 
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Figure captions 
Fig. 1. Scatter-plot for univariate associations between baseline telomere length (TL) measured in 2001-2004 
and Senior Fitness Test (SFT) results from follow-up in 2011-2013 for women and men. 
 
 
Fig. 2. Scatter-plot for univariate associations between follow-up telomere length (TL) and Senior Fitness 
Test (SFT) results for women and men. 
 
Fig. 3. Relationship between Senior Fitness Test (SFT) results from follow-up in 2011-2013 and relative 
telomere length at follow-up, measured as follow-up telomere length/baseline telomere length, for women and 
men. The curves were derived from 3-knot restricted cubic spline regression models. The models were adjusted 
for age, BMI, education years, smoking and follow-up time. Grey area represents 95% confidence intervals. 
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Table 1. Baseline characteristics of cohort members grouped by SFT tertiles at follow-up. Results are presented as means and standard deviations unless otherwise stated 
 
ap-values are calculated for linearity across tertiles 
SFT= Senior Fitness Test; HDL= High-density lipoprotein; LTPA= Leisure-time physical activity; MET= Metabolic equivalent of task; IQR= Interquartile range. 
  
 
 Women (n=582)  Men (n=453) 
SFT tertile (score range) I (5–39) II (40–55) III (56–100) p-valuea   I (5–33) II (34–50) III (52–100) p-valuea 
N 198 194 190   149 152 152  
Age (years) 61 (3) 61 (3) 61 (3)   61 (3) 61 (3) 60 (2)  
Body mass index (kg/m2) 29.0 (5.3) 26.8 (4.2) 25.4 (3.2) <0.001  28.4 (3.8) 27.2 (3.5) 26.1 (2.6) <0.001 
Current smoker or ex-smoker, n (%) 95 (48) 74 (38) 59 (31) <0.001  106 (71) 99 (65) 106 (70) 0.8 
Health status          
 Cardiovascular disease, n  (%) 39 (20) 29 (15) 15 (8) <0.001  35 (23) 30 (20) 19 (12) 0.01 
 Diabetes, n (%) 17 (9) 4 (2) 1 (1) <0.001  22 (15) 9 (6) 3 (2) <0.001 
 Asthma, n (%) 14 (7) 13 (7) 15 (8) 0.8  14 (9) 4 (3) 12 (8) 0.6 
 Plasma glucose (mmol/l) 5.7 (1.0) 5.5 (1.0) 5.3 (0.6) <0.001  6.4 (1.9) 5.9 (0.8) 5.7 (0.7) <0.001 
 Plasma total cholesterol  (mmol/l) 6.0 (1.1) 5.9 (0.9) 6.1 (1.0) 0.6  5.7 (1.1) 5.8 (1.0) 5.7 (1.0) 0.96 
 Plasma HDL cholesterol  (mmol/l) 1.7 (0.4) 1.7 (0.4) 1.9 (0.5) <0.001  1.4 (0.3) 1.5 (0.3) 1.6 (0.4) <0.001 
 Plasma triglycerides  (mmol/l) 1.5 (0.7) 1.4 (0.6) 1.2 (0.6) <0.001  1.7 (0.9) 1.5 (0.6) 1.3 (0.7) <0.001 
Education (years) 11.5 (3.4) 12.2 (3.4) 12.9 (3.4) <0.001  11.9 (3.5) 13.6 (3.9) 13.6 (3.8) <0.001 
LTPA (MET-h/year), median (IQR) 
1672 (895, 
2556) 
1607 (966, 
2561) 
1983 (1218, 
2853) 0.009  
1506 (992, 
2397) 
1809 (1020, 
2720) 
1662 (1248, 
2572) 0.1 
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Table 2. Cross-sectional and longitudinal univariable associations between telomere length and SFT result tertiles. 
 
 
ap-values are calculated for linearity across tertiles 
bCalculated as follow-up telomere length/baseline telomere length 
SFT= Senior Fitness Test 
  
 Women (n=582)  Men (n=453) 
SFT result (score range) I (5-39) II (40-55) III (56-100) p-valuea   I (5-33) II (34-50) III (52-100) p-valuea 
N 198 194 190   149 152 152  
Telomere length (T/S ratio)          
 Baseline, mean (SD) 1.42 (0.28) 1.41 (0.30) 1.42 (0.30) 0.87  1.37 (0.32) 1.38 (0.28) 1.39 (0.26) 0.45 
 Follow-up, mean (SD) 0.85 (0.26) 0.91 (0.33) 0.92 (0.36) 0.021  0.80 (0.27) 0.80 (0.26) 0.82 (0.27) 0.56 
Telomere attrition          
 Absolute change (T/S  ratio), 
mean (95% CI) 
-0.58 (-0.62 to -
0.53) 
-0.50 (-0.55 to -
0.44) 
-0.50 (-0.55 to -
0.44) 0.039  
-0.56 (-0.62 to -
0.50) 
-0.58 (-0.63 to -
0.52) 
-0.57 (-0.63 to -
0.52) 0.86 
 Relative telomere  lengthb 0.61 0.67 0.66     0.60 0.60 0.61   
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Table 3. Correlation between telomere length and individual SFT components 
 Telomere length 
 SFT component 
Baseline Absolute change 
r (95% CI) r (95% CI) 
Women (n=582)   
   Arm curl 0.01 (-0.07 to 0.09) 0.04 (-0.04 to 0.13) 
   Chair stand 0.04 (-0.04 to 0.12) 0.05 (-0.03 to 0.13) 
   Chair sit-and-reach -0.01 (-0.09 to 0.08) 0.04 (-0.04 to 0.12) 
   Back scratch -0.05 (-0.13 to 0.04) 0.06 (-0.03 to 0.14) 
   6-min walk 0.01 (-0.07 to 0.09) -0.01 (-0.09 to 0.08) 
Men (n=453)   
   Arm curl 0.07 (-0.02 to 0.16) 0.00 (-0.09 to 0.09) 
   Chair stand 0.10 (-0.01 to 0.19) -0.06 (-0.15 to 0.03) 
   Chair sit-and-reach 0.02 (-0.08 to 0.10) 0.02 (-0.07 to 0.11) 
   Back scratch -0.02 (-0.11 to 0.07) 0.02 (-0.07 to 0.11) 
   6-min walk 0.09 (-0.01 to 0.18) -0.05 (-0.14 to 0.04) 
SFT= Senior Fitness Test 
 
